10-08 Physician Research Points to a New Frontier for Stemtech Corporation: Nutritional Activation of the Body's Endogenous Regenerative System AQ
09-22 Physician Cites Stemtech as "Cornerstone" Behind His Focus on STEM Cell Medicine AQ
08-20 Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets AQ
08-15 Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-01 Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month" AQ
06-23 Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-30 Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
05-29 Stemtech Corporation Auditor Raises 'Going Concern' Doubt CI
04-07 Stemtech Secures Inventory Funding AQ
03-18 Stemtech Revolution 2026: A Bold New Era In Global Wellness AQ
01-06 Stemtech Corporation Appoints Dr. Lizette Leos, MD as Chief Scientific Officer CI
11-20 Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
19/08/25 Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
18/07/25 Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
01/07/25 Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 CI
30/06/25 Stemtech Corporation Auditor Raises 'Going Concern' Doubt CI
14/04/25 Stemtech Corporation Announces CFO Changes CI
19/02/25 Stemtech Corporation, Leading the Global Wellness, Anti-Aging Healthy Revolution AQ
12/12/24 Stemtech Corporation cancelled the acquisition of Eevia Health Oyj in a reverse merger transaction. CI
07/12/24 Stemtech : and Seacret Direct / Viago Execute Merger Agreement Form 8 K PU
02/12/24 Stemtech Corporation signed a letter of intent to acquire Eevia Health Oyj in a reverse merger transaction. CI
20/11/24 Stemtech Corporation entered into an agreement in principle to acquire SEACRET Direct, LLC for transaction valued at $32.5 million. CI
20/11/24 Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
26/09/24 Stemtech Corporation Sets Strategic Guidance and Expands into $303 Billion Pet Health Market CI
27/08/24 Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI

Become a member to access more news

New member
No results match your criteria
  1. Stock Market
  2. Stocks
  3. STEK Stock
  4. News Stemtech Corporation